Hologic Inc (HOLX)
Return on equity (ROE)
| Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 789,500 | 456,000 | 1,302,000 | 1,871,500 | 1,115,200 |
| Total stockholders’ equity | US$ in thousands | 5,130,000 | 5,016,900 | 4,876,200 | 4,218,600 | 2,705,200 |
| ROE | 15.39% | 9.09% | 26.70% | 44.36% | 41.22% |
September 30, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $789,500K ÷ $5,130,000K
= 15.39%
Hologic Inc's return on equity (ROE) has shown a fluctuating trend over the past five years. In 2024, the ROE stood at 15.39%, which was an improvement from the previous year's 9.09%. However, it was lower compared to the ROE in 2022 and 2021, which were 26.70% and 44.36% respectively, indicating a downward trend in profitability efficiency.
The significant decrease in ROE from 2021 to 2023 suggests a potential decline in the company's ability to generate profits from its shareholder's equity. However, the ROE in 2024 displayed a slight recovery, showing a positive sign for the company's profitability performance.
Overall, the fluctuating ROE trend of Hologic Inc indicates the need for further analysis to identify the factors affecting its return on equity and assess the company's overall financial health and performance.
Peer comparison
Sep 30, 2024